ACXP vs APH · $11.3M cap vs P/E 40, rev $23.09B
Acurx Pharmaceuticals LLC (ACXP) versus Amphenol Corporation (APH) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Amphenol Corporation (APH) is a electronic components company listed on US.
ACXP does not have a complete income-statement cache yet.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
ACXP currently screens at market cap $11.3M. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Not investment advice. Open the ACXP and APH stock pages for the full models.
Not investment advice.